SciClone Pharmaceuticals (Holdings) Ltd. is an investment holding company which manufactures and markets immune and oncology pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 1,050 full-time employees. The firm and its subsidiaries are principally engaged in developing and commercializing a portfolio of marketed products as well as pipelines with potential in their focused therapeutic areas including oncology and severe infection. The Company’s main products comprise Zadaxin, Zometa, Oravig, Angiomax, Endoxan, Holoxan, Cytosafe, Farlutal, Campto and Vizimpro. The Company’s pipeline products include ORSERDU, Vaborem, Vibativ, RRx-001 and Omburtamab. The Company’s products are mainly used in fields such as tumors, urinary tract infections, and skin and soft tissue infections. The firm mainly conducts its businesses in the domestic market.
06600.HK stock price ended at $100.7 on 金曜日, after rising 0.00%
On the latest trading day Jan 09, 2026, the stock price of 06600.HK rose by 0.00%, climbing from $103.50 to $100.70. During the session, the stock saw a volatility of 4.28%, with prices oscillating between a daily low of $99.25 and a high of $103.50. Notably, trading volume dropped by 100 shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 307.5K shares were traded, equating to a market value of approximately $22.3B.